A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke

Free Radical Biology and Medicine

Volumn 33, Issue 8, 2002, Pages 1141-1152

  Bowler, Russell P ^a   Sheng, Huaxin ^c   Enghild, Jan J ^b   Pearlstein, Robert D ^c   Warner, David S ^c   Crapo, James D ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AEOL 10150; Affymetrix; Antioxidant; Brain; Free radicals; Gene expression; Ischemia; Metalloporphyrin; Middle cerebral artery occlusion; Mouse

Indexed keywords

AEOL 10150; ANTIOXIDANT; HEAT SHOCK PROTEIN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MANGANESE MESO TETRAKIS(DI N ETHYLIMIDAZOLE)PORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CATALYSIS; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION REGULATION; IMMUNOMODULATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; REPERFUSION; RNA ANALYSIS; STROKE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BRAIN ISCHEMIA; CATALYSIS; CHEMOKINES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HEAT-SHOCK PROTEINS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; INFUSIONS, INTRAVENOUS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MURINAE;

EID: 0037108119     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01008-0     Document Type: Article

References (64)

1. Patel M., Day B.J. Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol. Sci. 20:1999;359-364.
2. Oury T.D., Thakker K., Menache M., Chang L.Y., Crapo J.D., Day B.J. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin. Am. J. Respir. Cell. Mol. Biol. 25:2001;164-169.
3. Day B.J., Crapo J.D. A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced lung injury in vivo. Toxicol. Appl. Pharmacol. 140:1996;94-100.
4. Liang L.P., Ho Y.S., Patel M. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience. 101:2001;563-570.
5. Mackensen G.B., Patel M., Sheng H., Calvi C.L., Batinic-Haberle I., Day B.J., Liang L.P., Fridovich I., Crapo J.D., Pearlstein R.D., Warner D.S. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. J. Neurosci. 21:2001;4582-4592.
6. Sheng H., Enghild J.J., Bowler R., Patel M., Batinić-Haberle I., Calvi C.L., Day B.J., Pearlstein R.D., Crapo J.D., Warner D.S. Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic. Biol. Med. 33:2002;947-961.
7. Endres M., Fan G., Hirt L., Fujii M., Matsushita K., Liu X., Jaenisch R., Moskowitz M.A. Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression. J. Cereb. Blood Flow Metab. 20:2000;139-144.
8. Iadecola C., Salkowski C.A., Zhang F., Aber T., Nagayama M., Vogel S.N., Ross M.E. The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury. J. Exp. Med. 189:1999;719-727.
9. Asahi M., Asahi K., Jung J.C., del Zoppo G.J., Fini M.E., Lo E.H. Role for matrix metalloproteinase 9 after focal cerebral ischemia effects of gene knockout and enzyme inhibition with BB-94 . J. Cereb. Blood Flow Metab. 20:2000;1681-1689.
10. Connolly E.S. Jr, Winfree C.J., Springer T.A., Naka Y., Liao H., Yan S.D., Stern D.M., Solomon R.A., Gutierrez-Ramos J.C., Pinsky D.J. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97:1996;209-216.
11. Alkayed N.J., Goto S., Sugo N., Joh H.D., Klaus J., Crain B.J., Bernard O., Traystman R.J., Hurn P.D. Estrogen and Bcl-2 gene induction and effect of transgene in experimental stroke . J. Neurosci. 21:2001;7543-7550.
12. Rajdev S., Hara K., Kokubo Y., Mestril R., Dillmann W., Weinstein P.R., Sharp F.R. Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction. Ann. Neurol. 47:2000;782-791.
13. Levi-Strauss M., Carroll M.C., Steinmetz M., Meo T. A previously undetected MHC gene with an unusual periodic structure. Science. 240:1988;201-214.
14. Borowsky B., Walker M.W., Bard J., Weinshank R.L., Laz T.M., Vaysse P., Branchek T.A., Gerald C. Molecular biology and pharmacology of multiple NPY Y5 receptor species homologs. Regul. Pept. 75-76:1998;45-53.
15. Chen J., Graham S.H., Zhu R.L., Simon R.P. Stress proteins and tolerance to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 16:1996;566-577.
16. Hara T., Mies G., Hata R., Hossmann K.A. Gene expressions after thrombolytic treatment of middle cerebral artery clot embolism in mice. Stroke. 32:2001;1912-1919.
17. Hata R., Maeda K., Hermann D., Mies G., Hossmann K.A. Evolution of brain infarction after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 20:2000;937-946.
18. del Zoppo G., Ginis I., Hallenbeck J.M., Iadecola C., Wang X., Feuerstein G.Z. Inflammation and stroke putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia . Brain Pathol. 10:2000;95-112.
19. Kogure K., Yamasaki Y., Matsuo Y., Kato H., Onodera H. Inflammation of the brain after ischemia. Acta Neurochir. 66:(Suppl.):1996;40-43.
20. Wang X., Li X., Currie R.W., Willette R.N., Barone F.C., Feuerstein G.Z. Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1beta mRNA in ischemic brain tolerance. J. Neurosci. Res. 59:2000;238-246.
21. Ali C., Nicole O., Docagne F., Lesne S., MacKenzie E.T., Nouvelot A., Buisson A., Vivien D. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J. Cereb. Blood Flow Metab. 20:2000;956-966.
22. Bona E., Andersson A.L., Blomgren K., Gilland E., Puka-Sundvall M., Gustafson K., Hagberg H. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr. Res. 45:1999;500-509.
23. Rollins B.J. JE/MCP-1 an early-response gene encodes a monocyte-specific cytokine . Cancer Cells. 3:1991;517-524.
24. Safirstein R., Megyesi J., Saggi S.J., Price P.M., Poon M., Rollins B.J., Taubman M.B. Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am. J. Physiol. 261:1991;F1095-F1101.
25. Van Beek J., Bernaudin M., Petit E., Gasque P., Nouvelot A., MacKenzie E.T., Fontaine M. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp. Neurol. 161:2000;373-382.
26. Wisniewski H.G., Vilcek J. TSG-6 an IL-1/TNF-inducible protein with anti-inflammatory activity . Cytokine Growth Factor Rev. 8:1997;143-156.
27. Biber K., Sauter A., Brouwer N., Copray S.C., Boddeke H.W. Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). Glia. 34:2001;121-133.
28. Medhurst A.D., Harrison D.C., Read S.J., Campbell C.A., Robbins M.J., Pangalos M.N. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J. Neurosci. Methods. 98:2000;9-20.
29. Krupinski J., Kumar P., Kumar S., Kaluza J. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke. 27:1996;852-857.
30. Akgur F.M., Brown M.F., Zibari G.B., McDonald J.C., Epstein C.J., Ross C.R., Granger D.N. Role of superoxide in hemorrhagic shock-induced P-selectin expression. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H791-H797.
31. Huang J., Choudhri T.F., Winfree C.J., McTaggart R.A., Kiss S., Mocco J., Kim L.J., Protopsaltis T.S., Zhang Y., Pinsky D.J., Connolly E.S. Jr. Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke. 31:2000;3047-3053.
32. Suzuki H., Hayashi T., Tojo S.J., Kitagawa H., Kimura K., Mizugaki M., Itoyama Y., Abe K. Anti-P-selectin antibody attenuates rat brain ischemic injury. Neurosci. Lett. 265:1999;163-166.
33. Matsuo Y., Onodera H., Shiga Y., Shozuhara H., Ninomiya M., Kihara T., Tamatani T., Miyasaka M., Kogure K. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 656:1994;344-352.
34. Sampei K., Mandir A.S., Asano Y., Wong P.C., Traystman R.J., Dawson V.L., Dawson T.M., Hurn P.D. Stroke outcome in double-mutant antioxidant transgenic mice. Stroke. 31:2000;2685-2691.
35. Sheng H., Brady T.C., Pearlstein R.D., Crapo J.D., Warner D.S. Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neurosci. Lett. 267:1999;13-16.
36. Crack P.J., Taylor J.M., Flentjar N.J., de Haan J., Hertzog P., Iannello R.C., Kola I. Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J. Neurochem. 78:2001;1389-1399.
37. Takagi Y., Mitsui A., Nishiyama A., Nozaki K., Sono H., Gon Y., Hashimoto N., Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc. Natl. Acad. Sci. USA. 96:1999;4131-4136.
38. Yang G.Y., Pang L., Ge H.L., Tan M., Ye W., Liu X.H., Huang F.P., Wu D.C., Che X.M., Song Y., Wen R., Sun Y. Attenuation of ischemia-induced mouse brain injury by SAG, a redox- inducible antioxidant protein. J. Cereb Blood Flow Metab. 21:2001;722-733.
39. Yamagata K., Tagami M., Ikeda K., Yamori Y., Nara Y. Altered gene expressions during hypoxia and reoxygenation in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Neurosci. Lett. 284:2000;131-134.
40. Mattson M.P., Culmsee C., Yu Z.F. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res. 301:2000;173-187.
41. Hermann D.M., Kuroiwa T., Hata R., Gillardon F., Ito U., Mies G. Expression of redox factor-1, p53-activated gene 608 and caspase-3 messenger RNAs following repeated unilateral common carotid artery occlusion in gerbils - relationship to delayed cell injury and secondary failure of energy state. Neuroscience. 102:2001;779-787.
42. Sarabi A., Chang C.F., Wang Y., Hoffer B.J., Morales M. Time course study of GFRalpha-1 expression in an animal model of stroke. Exp. Neurol. 170:2001;283-289.
43. Kinoshita Y., Ueyama T., Senba E., Terada T., Nakai K., Itakura T. Expression of c-fos, heat shock protein 70, neurotrophins, and cyclooxygenase-2 mRNA in response to focal cerebral ischemia/reperfusion in rats and their modification by magnesium sulfate. J. Neurotrauma. 18:2001;435-445.
44. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats inhibition of matrix metalloproteinase-9 reduces infarct size . Stroke. 29:1998;1020-1030.
45. Lin T.N., Wang C.K., Cheung W.M., Hsu C.Y. Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 20:2000;387-395.
46. Ito T., Takenaka K., Sakai H., Yoshimura S., Hayashi K., Noda S., Sakai N. Elevation of mRNA levels of tissue-type plasminogen activator and urokinase-type plasminogen activator in hippocampus and cerebral cortex following middle cerebral artery occlusion in rats. Neurol. Res. 22:2000;413-419.
47. Cheung W.M., Wang C.K., Kuo J.S., Lin T.N. Changes in the level of glial fibrillary acidic protein (GFAP) after mild and severe focal cerebral ischemia. Chin. J. Physiol. 42:1999;227-235.
48. Taniguchi M., Yamashita T., Kumura E., Tamatani M., Kobayashi A., Yokawa T., Maruno M., Kato A., Ohnishi T., Kohmura E., Tohyama M., Yoshimine T. Induction of aquaporin-4 water channel mRNA after focal cerebral ischemia in rat. Brain Res. Mol. Brain Res. 78:2000;131-137.
49. Trapp T., Olah L., Holker I., Besselmann M., Tiesler C., Maeda K., Hossmann K.A. GTPase RhoB an early predictor of neuronal death after transient focal ischemia in mice . Mol. Cell. Neurosci. 17:2001;883-894.
50. Kochanek P.M., Hallenbeck J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 23:1992;1367-1379.
51. Hallenbeck J.M. Cytokines, macrophages, and leukocytes in brain ischemia. Neurology. 49:(Suppl. 4):1997;S5-S9.
52. Wang M.J., Huang H.M., Hsieh S.J., Jeng K.C., Kuo J.S. Resveratrol inhibits interleukin-6 production in cortical mixed glial cells under hypoxia/hypoglycemia followed by reoxygenation. J. Neuroimmunol. 112:2001;28-34.
53. Volk T., Hensel M., Schuster H., Kox W.J. Secretion of MCP-1 and IL-6 by cytokine stimulated production of reactive oxygen species in endothelial cells. Mol. Cell. Biochem. 206:2000;105-112.
54. Satriano J.A., Shuldiner M., Hora K., Xing Y., Shan Z., Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J. Clin. Invest. 92:1993;1564-1571.
55. Dihne M., Block F. Focal ischemia induces transient expression of IL-6 in the substantia nigra pars reticulata. Brain Res. 889:2001;165-173.
56. Vila N., Castillo J., Davalos A., Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 31:2000;2325-2329.
57. Clark W.M., Rinker L.G., Lessov N.S., Hazel K., Hill J.K., Stenzel-Poore M., Eckenstein F. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke. 31:2000;1715-1720.
58. Gosslau A., Rensing L. Induction of Hsp68 by oxidative stress involves the lipoxygenase pathway in C6 rat glioma cells. Brain Res. 864:2000;114-123.
59. Bagchi D., Bhattacharya G., Stohs S.J. In vitro and in vivo induction of heat shock (stress) protein (Hsp) gene expression by selected pesticides. Toxicology. 112:1996;57-68.
60. Seegers H., Grillon E., Trioullier Y., Vath A., Verna J.M., Blum D. Nuclear factor-kappa B activation in permanent intraluminal focal cerebral ischemia in the rat. Neurosci. Lett. 288:2000;241-245.
61. Issa R., Krupinski J., Bujny T., Kumar S., Kaluza J., Kumar P. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab. Invest. 79:1999;417-425.
62. Nowak T.S. Jr, Jacewicz M. The heat shock/stress response in focal cerebral ischemia. Brain Pathol. 4:1994;67-76.
63. Kiessling M., Gass P. Stimulus-transcription coupling in focal cerebral ischemia. Brain Pathol. 4:1994;77-83.
64. Li Q.Y., Pedersen C., Day B.J., Patel M. Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation. J. Neurochem. 78:2001;746-755.